Loading…

Vitamin D receptor gene polymorphisms in Alzheimer's disease patients

The aim of this study was to determine whether polymorphisms of the VDR gene may increase the risk of Alzheimer disease (AD) development in Lower Silesian patients in comparison with other populations. 108 AD patients (aged 73.7±8.6) vs 77 healthy volunteers (aged 64.5±7.8) in the Lower Silesian pop...

Full description

Saved in:
Bibliographic Details
Published in:Experimental gerontology 2015-09, Vol.69, p.142-147
Main Authors: Łaczmański, Łukasz, Jakubik, Marta, Bednarek-Tupikowska, Grażyna, Rymaszewska, Joanna, Słoka, Natalia, Lwow, Felicja
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c359t-31db54afd342e311a8ce133d647773e3fff2dda5141dcfd80f87a417b40a3cb3
cites cdi_FETCH-LOGICAL-c359t-31db54afd342e311a8ce133d647773e3fff2dda5141dcfd80f87a417b40a3cb3
container_end_page 147
container_issue
container_start_page 142
container_title Experimental gerontology
container_volume 69
creator Łaczmański, Łukasz
Jakubik, Marta
Bednarek-Tupikowska, Grażyna
Rymaszewska, Joanna
Słoka, Natalia
Lwow, Felicja
description The aim of this study was to determine whether polymorphisms of the VDR gene may increase the risk of Alzheimer disease (AD) development in Lower Silesian patients in comparison with other populations. 108 AD patients (aged 73.7±8.6) vs 77 healthy volunteers (aged 64.5±7.8) in the Lower Silesian population were studied. We investigated the frequency of the VDR polymorphisms rs731236 (TaqI), rs7975232 (ApaI), rs10735810 (FokI) and rs1544410 (BsmI) in the AD group vs the healthy group. Afterwards, MEDLINE and ResearchGate were studied to compare our investigation with other populations, due to the relatively small group size in our study. We did not observe any significant differences in frequency of genotypes of rs731236 (TaqI), rs10735810 (FokI) or rs1544410 (BsmI) VDR polymorphisms between the two Lower Silesian groups. Frequency of allele A of ApaI in the control group was significantly higher vs AD patients (p
doi_str_mv 10.1016/j.exger.2015.06.012
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1708161900</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0531556515001904</els_id><sourcerecordid>1708161900</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-31db54afd342e311a8ce133d647773e3fff2dda5141dcfd80f87a417b40a3cb3</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EgvL4AiSUHWwSZuLYSRcsUHlKldggtpZrT1pXSRPsFFG-HkOBJavZnHuv5jB2ipAhoLxcZvQ-J5_lgCIDmQHmO2yEVclTWaHYZSMQHFMhpDhghyEsAUDmHPfZQS5hzEHAiN2-uEG3bpXcJJ4M9UPnkzmtKOm7ZtN2vl-40IYkAtfNx4JcS_48JNYF0iFCenC0GsIx26t1E-jk5x6x57vb58lDOn26f5xcT1PDxXhIOdqZKHRteZETR9SVIeTcyqIsS068ruvcWi2wQGtqW0FdlbrAclaA5mbGj9jFtrb33euawqBaFww1jV5Rtw4KS6hQ4hggonyLGt-F4KlWvXet9huFoL70qaX61qe-9CmQKuqLqbOfgfWsJfuX-fUVgastQPHLNxfjwUQDhqyL-gZlO_fvwCfl0oJA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1708161900</pqid></control><display><type>article</type><title>Vitamin D receptor gene polymorphisms in Alzheimer's disease patients</title><source>ScienceDirect Freedom Collection</source><source>ScienceDirect Journals</source><creator>Łaczmański, Łukasz ; Jakubik, Marta ; Bednarek-Tupikowska, Grażyna ; Rymaszewska, Joanna ; Słoka, Natalia ; Lwow, Felicja</creator><creatorcontrib>Łaczmański, Łukasz ; Jakubik, Marta ; Bednarek-Tupikowska, Grażyna ; Rymaszewska, Joanna ; Słoka, Natalia ; Lwow, Felicja</creatorcontrib><description>The aim of this study was to determine whether polymorphisms of the VDR gene may increase the risk of Alzheimer disease (AD) development in Lower Silesian patients in comparison with other populations. 108 AD patients (aged 73.7±8.6) vs 77 healthy volunteers (aged 64.5±7.8) in the Lower Silesian population were studied. We investigated the frequency of the VDR polymorphisms rs731236 (TaqI), rs7975232 (ApaI), rs10735810 (FokI) and rs1544410 (BsmI) in the AD group vs the healthy group. Afterwards, MEDLINE and ResearchGate were studied to compare our investigation with other populations, due to the relatively small group size in our study. We did not observe any significant differences in frequency of genotypes of rs731236 (TaqI), rs10735810 (FokI) or rs1544410 (BsmI) VDR polymorphisms between the two Lower Silesian groups. Frequency of allele A of ApaI in the control group was significantly higher vs AD patients (p&lt;0.0177) in the Lower Silesian population. Furthermore the difference in the occurrence of allele t in TaqI and allele A in ApaI between AD patients vs the control group was significant (respectively p&lt;0.0056, p&lt;0.0140) in British Europeans. This observation may suggest that allele “a” of the ApaI polymorphism is a risk allele in AD Lower Silesian patients. We compared our results with those obtained for the population of British Europeans. In multivariate stepwise regression, allele “A” of ApaI was associated with 30% lower risk of AD (OR=0.70, p=0.0009) in total treated Polish and British populations. We did not observe similar results in Turkish and Iranian populations. Our data suggest that the allele “A” VDR genotype of ApaI reduces AD risk, probably depending on ethnic origin and climatic conditions. •We describe the frequency of the VDR polymorphisms in AD vs a control group.•We summarize our investigations and refer to previously described data.•We used the meta-analysis method.•It is suggested that the rare VDR genotype increases AD risk.•It is depending on ethnic origin and climatic conditions.</description><identifier>ISSN: 0531-5565</identifier><identifier>EISSN: 1873-6815</identifier><identifier>DOI: 10.1016/j.exger.2015.06.012</identifier><identifier>PMID: 26093050</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Aged ; Aged, 80 and over ; Alzheimer Disease - epidemiology ; Alzheimer Disease - genetics ; Female ; Gene Frequency ; Genetic Predisposition to Disease ; Humans ; Iran - epidemiology ; Male ; Middle Aged ; Poland - epidemiology ; Polymorphism, Restriction Fragment Length ; Polymorphism, Single Nucleotide ; Receptors, Calcitriol - genetics ; Turkey - epidemiology ; United Kingdom - epidemiology ; VDR polymorphism</subject><ispartof>Experimental gerontology, 2015-09, Vol.69, p.142-147</ispartof><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c359t-31db54afd342e311a8ce133d647773e3fff2dda5141dcfd80f87a417b40a3cb3</citedby><cites>FETCH-LOGICAL-c359t-31db54afd342e311a8ce133d647773e3fff2dda5141dcfd80f87a417b40a3cb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0531556515001904$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27901,27902,45756</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26093050$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Łaczmański, Łukasz</creatorcontrib><creatorcontrib>Jakubik, Marta</creatorcontrib><creatorcontrib>Bednarek-Tupikowska, Grażyna</creatorcontrib><creatorcontrib>Rymaszewska, Joanna</creatorcontrib><creatorcontrib>Słoka, Natalia</creatorcontrib><creatorcontrib>Lwow, Felicja</creatorcontrib><title>Vitamin D receptor gene polymorphisms in Alzheimer's disease patients</title><title>Experimental gerontology</title><addtitle>Exp Gerontol</addtitle><description>The aim of this study was to determine whether polymorphisms of the VDR gene may increase the risk of Alzheimer disease (AD) development in Lower Silesian patients in comparison with other populations. 108 AD patients (aged 73.7±8.6) vs 77 healthy volunteers (aged 64.5±7.8) in the Lower Silesian population were studied. We investigated the frequency of the VDR polymorphisms rs731236 (TaqI), rs7975232 (ApaI), rs10735810 (FokI) and rs1544410 (BsmI) in the AD group vs the healthy group. Afterwards, MEDLINE and ResearchGate were studied to compare our investigation with other populations, due to the relatively small group size in our study. We did not observe any significant differences in frequency of genotypes of rs731236 (TaqI), rs10735810 (FokI) or rs1544410 (BsmI) VDR polymorphisms between the two Lower Silesian groups. Frequency of allele A of ApaI in the control group was significantly higher vs AD patients (p&lt;0.0177) in the Lower Silesian population. Furthermore the difference in the occurrence of allele t in TaqI and allele A in ApaI between AD patients vs the control group was significant (respectively p&lt;0.0056, p&lt;0.0140) in British Europeans. This observation may suggest that allele “a” of the ApaI polymorphism is a risk allele in AD Lower Silesian patients. We compared our results with those obtained for the population of British Europeans. In multivariate stepwise regression, allele “A” of ApaI was associated with 30% lower risk of AD (OR=0.70, p=0.0009) in total treated Polish and British populations. We did not observe similar results in Turkish and Iranian populations. Our data suggest that the allele “A” VDR genotype of ApaI reduces AD risk, probably depending on ethnic origin and climatic conditions. •We describe the frequency of the VDR polymorphisms in AD vs a control group.•We summarize our investigations and refer to previously described data.•We used the meta-analysis method.•It is suggested that the rare VDR genotype increases AD risk.•It is depending on ethnic origin and climatic conditions.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alzheimer Disease - epidemiology</subject><subject>Alzheimer Disease - genetics</subject><subject>Female</subject><subject>Gene Frequency</subject><subject>Genetic Predisposition to Disease</subject><subject>Humans</subject><subject>Iran - epidemiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Poland - epidemiology</subject><subject>Polymorphism, Restriction Fragment Length</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Receptors, Calcitriol - genetics</subject><subject>Turkey - epidemiology</subject><subject>United Kingdom - epidemiology</subject><subject>VDR polymorphism</subject><issn>0531-5565</issn><issn>1873-6815</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRS0EgvL4AiSUHWwSZuLYSRcsUHlKldggtpZrT1pXSRPsFFG-HkOBJavZnHuv5jB2ipAhoLxcZvQ-J5_lgCIDmQHmO2yEVclTWaHYZSMQHFMhpDhghyEsAUDmHPfZQS5hzEHAiN2-uEG3bpXcJJ4M9UPnkzmtKOm7ZtN2vl-40IYkAtfNx4JcS_48JNYF0iFCenC0GsIx26t1E-jk5x6x57vb58lDOn26f5xcT1PDxXhIOdqZKHRteZETR9SVIeTcyqIsS068ruvcWi2wQGtqW0FdlbrAclaA5mbGj9jFtrb33euawqBaFww1jV5Rtw4KS6hQ4hggonyLGt-F4KlWvXet9huFoL70qaX61qe-9CmQKuqLqbOfgfWsJfuX-fUVgastQPHLNxfjwUQDhqyL-gZlO_fvwCfl0oJA</recordid><startdate>201509</startdate><enddate>201509</enddate><creator>Łaczmański, Łukasz</creator><creator>Jakubik, Marta</creator><creator>Bednarek-Tupikowska, Grażyna</creator><creator>Rymaszewska, Joanna</creator><creator>Słoka, Natalia</creator><creator>Lwow, Felicja</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201509</creationdate><title>Vitamin D receptor gene polymorphisms in Alzheimer's disease patients</title><author>Łaczmański, Łukasz ; Jakubik, Marta ; Bednarek-Tupikowska, Grażyna ; Rymaszewska, Joanna ; Słoka, Natalia ; Lwow, Felicja</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-31db54afd342e311a8ce133d647773e3fff2dda5141dcfd80f87a417b40a3cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alzheimer Disease - epidemiology</topic><topic>Alzheimer Disease - genetics</topic><topic>Female</topic><topic>Gene Frequency</topic><topic>Genetic Predisposition to Disease</topic><topic>Humans</topic><topic>Iran - epidemiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Poland - epidemiology</topic><topic>Polymorphism, Restriction Fragment Length</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Receptors, Calcitriol - genetics</topic><topic>Turkey - epidemiology</topic><topic>United Kingdom - epidemiology</topic><topic>VDR polymorphism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Łaczmański, Łukasz</creatorcontrib><creatorcontrib>Jakubik, Marta</creatorcontrib><creatorcontrib>Bednarek-Tupikowska, Grażyna</creatorcontrib><creatorcontrib>Rymaszewska, Joanna</creatorcontrib><creatorcontrib>Słoka, Natalia</creatorcontrib><creatorcontrib>Lwow, Felicja</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental gerontology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Łaczmański, Łukasz</au><au>Jakubik, Marta</au><au>Bednarek-Tupikowska, Grażyna</au><au>Rymaszewska, Joanna</au><au>Słoka, Natalia</au><au>Lwow, Felicja</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vitamin D receptor gene polymorphisms in Alzheimer's disease patients</atitle><jtitle>Experimental gerontology</jtitle><addtitle>Exp Gerontol</addtitle><date>2015-09</date><risdate>2015</risdate><volume>69</volume><spage>142</spage><epage>147</epage><pages>142-147</pages><issn>0531-5565</issn><eissn>1873-6815</eissn><abstract>The aim of this study was to determine whether polymorphisms of the VDR gene may increase the risk of Alzheimer disease (AD) development in Lower Silesian patients in comparison with other populations. 108 AD patients (aged 73.7±8.6) vs 77 healthy volunteers (aged 64.5±7.8) in the Lower Silesian population were studied. We investigated the frequency of the VDR polymorphisms rs731236 (TaqI), rs7975232 (ApaI), rs10735810 (FokI) and rs1544410 (BsmI) in the AD group vs the healthy group. Afterwards, MEDLINE and ResearchGate were studied to compare our investigation with other populations, due to the relatively small group size in our study. We did not observe any significant differences in frequency of genotypes of rs731236 (TaqI), rs10735810 (FokI) or rs1544410 (BsmI) VDR polymorphisms between the two Lower Silesian groups. Frequency of allele A of ApaI in the control group was significantly higher vs AD patients (p&lt;0.0177) in the Lower Silesian population. Furthermore the difference in the occurrence of allele t in TaqI and allele A in ApaI between AD patients vs the control group was significant (respectively p&lt;0.0056, p&lt;0.0140) in British Europeans. This observation may suggest that allele “a” of the ApaI polymorphism is a risk allele in AD Lower Silesian patients. We compared our results with those obtained for the population of British Europeans. In multivariate stepwise regression, allele “A” of ApaI was associated with 30% lower risk of AD (OR=0.70, p=0.0009) in total treated Polish and British populations. We did not observe similar results in Turkish and Iranian populations. Our data suggest that the allele “A” VDR genotype of ApaI reduces AD risk, probably depending on ethnic origin and climatic conditions. •We describe the frequency of the VDR polymorphisms in AD vs a control group.•We summarize our investigations and refer to previously described data.•We used the meta-analysis method.•It is suggested that the rare VDR genotype increases AD risk.•It is depending on ethnic origin and climatic conditions.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>26093050</pmid><doi>10.1016/j.exger.2015.06.012</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0531-5565
ispartof Experimental gerontology, 2015-09, Vol.69, p.142-147
issn 0531-5565
1873-6815
language eng
recordid cdi_proquest_miscellaneous_1708161900
source ScienceDirect Freedom Collection; ScienceDirect Journals
subjects Aged
Aged, 80 and over
Alzheimer Disease - epidemiology
Alzheimer Disease - genetics
Female
Gene Frequency
Genetic Predisposition to Disease
Humans
Iran - epidemiology
Male
Middle Aged
Poland - epidemiology
Polymorphism, Restriction Fragment Length
Polymorphism, Single Nucleotide
Receptors, Calcitriol - genetics
Turkey - epidemiology
United Kingdom - epidemiology
VDR polymorphism
title Vitamin D receptor gene polymorphisms in Alzheimer's disease patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T02%3A35%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vitamin%20D%20receptor%20gene%20polymorphisms%20in%20Alzheimer's%20disease%20patients&rft.jtitle=Experimental%20gerontology&rft.au=%C5%81aczma%C5%84ski,%20%C5%81ukasz&rft.date=2015-09&rft.volume=69&rft.spage=142&rft.epage=147&rft.pages=142-147&rft.issn=0531-5565&rft.eissn=1873-6815&rft_id=info:doi/10.1016/j.exger.2015.06.012&rft_dat=%3Cproquest_cross%3E1708161900%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c359t-31db54afd342e311a8ce133d647773e3fff2dda5141dcfd80f87a417b40a3cb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1708161900&rft_id=info:pmid/26093050&rfr_iscdi=true